Muyco, Xyrus Jake .

HRN: 25-76-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/19/2025
IVT
750mg
OD
PCAP-C
Checking Final Appropriateness 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  PneumoniaDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: